Treatment of CT26, MC38 mouse tumor cells with 1 ng/ml and A20 with 0.3 ng/ml IFN-β resulted in reduction in tumor cell proliferation in vitro (Fig. 8a). This evidence concerns the gene IFNB1 and neoplasm.